Page last updated: 2024-09-05

organophosphonates and docetaxel anhydrous

organophosphonates has been researched along with docetaxel anhydrous in 2 studies

Compound Research Comparison

Studies (organophosphonates)	Trials (organophosphonates)	Recent Studies (post-2010) (organophosphonates)	Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)
9,968	880	3,596	12,110	3,216	6,920

Protein Interaction Comparison

Protein	Taxonomy	organophosphonates (IC50)	docetaxel anhydrous (IC50)
Kinesin-like protein KIF11	Homo sapiens (human)		0.0014
Nucleotide-binding oligomerization domain-containing protein 2	Homo sapiens (human)		5.0119

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kennedy, MJ	1
Chen, Y; Gera, L; Kucuk, O; Li, X; Liu, H; Mamouni, K; Wu, AY; Wu, D; Yang, Y; Zhang, S	1

Reviews

1 review(s) available for organophosphonates and docetaxel anhydrous

Article	Year
Metastatic breast cancer. Current opinion in oncology, 1996, Volume: 8, Issue:6 Topics: Adenine; Antibodies, Monoclonal; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Diphosphonates; Docetaxel; Doxorubicin; Enzyme Inhibitors; Female; Gemcitabine; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Neoplasm Metastasis; Neoplasm Proteins; Organophosphonates; Paclitaxel; Randomized Controlled Trials as Topic; Salvage Therapy; Taxoids; Topoisomerase II Inhibitors; Treatment Outcome	1996

Article

Year

Metastatic breast cancer.

Current opinion in oncology, 1996, Volume: 8, Issue:6

Topics: Adenine; Antibodies, Monoclonal; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Deoxycytidine; Diphosphonates; Docetaxel; Doxorubicin; Enzyme Inhibitors; Female; Gemcitabine; Humans; Imides; Intercalating Agents; Isoquinolines; Naphthalimides; Neoplasm Metastasis; Neoplasm Proteins; Organophosphonates; Paclitaxel; Randomized Controlled Trials as Topic; Salvage Therapy; Taxoids; Topoisomerase II Inhibitors; Treatment Outcome

1996

Other Studies

1 other study(ies) available for organophosphonates and docetaxel anhydrous

Article	Year
Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models. Cancer letters, 2019, 04-01, Volume: 446 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Bradykinin Receptor Antagonists; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Organophosphonates; Phosphorylation; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Survivin; Tumor Burden; Xenograft Model Antitumor Assays	2019

Article

Year

Small molecule BKM1972 inhibits human prostate cancer growth and overcomes docetaxel resistance in intraosseous models.

Cancer letters, 2019, 04-01, Volume: 446

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Bradykinin Receptor Antagonists; Cell Line, Tumor; Cell Proliferation; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Organophosphonates; Phosphorylation; Prostatic Neoplasms; Signal Transduction; STAT3 Transcription Factor; Survivin; Tumor Burden; Xenograft Model Antitumor Assays

2019